Clean Yield Group Sells 11,151 Shares of Smith & Nephew plc (NYSE:SNN)

Clean Yield Group lessened its stake in shares of Smith & Nephew plc (NYSE:SNN) by 5.6% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 186,414 shares of the medical equipment provider’s stock after selling 11,151 shares during the quarter. Smith & Nephew makes up 1.5% of Clean Yield Group’s holdings, making the stock its 19th biggest holding. Clean Yield Group’s holdings in Smith & Nephew were worth $4,582,000 as of its most recent filing with the SEC.

Several other institutional investors also recently modified their holdings of the stock. EverSource Wealth Advisors LLC boosted its holdings in shares of Smith & Nephew by 92.5% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,454 shares of the medical equipment provider’s stock valued at $61,000 after acquiring an additional 1,179 shares in the last quarter. GAMMA Investing LLC increased its holdings in Smith & Nephew by 160.0% in the 3rd quarter. GAMMA Investing LLC now owns 2,257 shares of the medical equipment provider’s stock worth $70,000 after purchasing an additional 1,389 shares in the last quarter. Allspring Global Investments Holdings LLC raised its position in Smith & Nephew by 74.4% in the third quarter. Allspring Global Investments Holdings LLC now owns 3,025 shares of the medical equipment provider’s stock valued at $94,000 after purchasing an additional 1,290 shares during the last quarter. Blue Trust Inc. boosted its stake in shares of Smith & Nephew by 460.5% during the third quarter. Blue Trust Inc. now owns 4,658 shares of the medical equipment provider’s stock valued at $145,000 after purchasing an additional 3,827 shares in the last quarter. Finally, Coerente Capital Management bought a new stake in shares of Smith & Nephew during the third quarter worth about $202,000. 25.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on SNN. Deutsche Bank Aktiengesellschaft lowered shares of Smith & Nephew from a “buy” rating to a “hold” rating in a report on Friday, November 1st. Berenberg Bank lowered shares of Smith & Nephew from a “buy” rating to a “hold” rating in a report on Wednesday, November 6th. Finally, StockNews.com downgraded Smith & Nephew from a “strong-buy” rating to a “buy” rating in a report on Tuesday, November 12th.

Smith & Nephew Trading Up 0.3 %

Shares of SNN traded up $0.08 during mid-day trading on Monday, reaching $24.03. 450,440 shares of the company were exchanged, compared to its average volume of 1,106,965. The business has a 50 day simple moving average of $25.00 and a two-hundred day simple moving average of $27.79. Smith & Nephew plc has a 52 week low of $23.65 and a 52 week high of $31.72. The stock has a market capitalization of $10.51 billion, a PE ratio of 12.26, a PEG ratio of 1.41 and a beta of 0.84. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.11 and a current ratio of 2.51.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.